Status:
COMPLETED
Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary Prevention
Lead Sponsor:
AstraZeneca
Conditions:
Peripheral Arterial Disease (PAD)
Moderate Risk for Cardiovascular Disease (CVD)
Eligibility:
All Genders
45+ years
Brief Summary
Non interventional study aimed to establish the prevalence of lower extremity peripheral arterial disease (PAD), defined as an ankle-brachial index (ABI) not above 0.90 in subjects with a moderate ris...
Eligibility Criteria
Inclusion
- Male subject aged 45 years or above, or female subject aged 55 years or above (age-related CVD risk factor)
- At least another of the following risk factor for CVD: cigarette smoking, hypertension, low HDL cholesterol or high LDL cholesterol, family history of premature coronary heart disease, elevated waist circumference
- Willingness to participate in the survey and complying with the study by signing a written informed consent
Exclusion
- No or 1 risk factor for CVD; symptoms of PAD; diabetes mellitus; coronary heart disease or equivalents
- No lipid data collected in the last 12 months
- Serious or unstable medical or psychological conditions that, in the opinion of the Investigator, would compromise the subject's safety or successful participation in the study; unwilling or unable to provide informed consent
Key Trial Info
Start Date :
May 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
9000 Patients enrolled
Trial Details
Trial ID
NCT00689377
Start Date
May 1 2007
End Date
July 1 2008
Last Update
March 20 2012
Active Locations (331)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Chênée, Liege, Belgium
2
Research Site
Aarschot, Belgium
3
Research Site
Alsemberg, Belgium
4
Research Site
Anderlecht, Belgium